Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
Sánchez-López E, Egea MA, Cano A, Espina M, Calpena AC, Ettcheto M, Camins A, Souto EB, Silva AM, García ML. Sánchez-López E, et al. Among authors: cano a. Colloids Surf B Biointerfaces. 2016 Sep 1;145:241-250. doi: 10.1016/j.colsurfb.2016.04.054. Epub 2016 May 3. Colloids Surf B Biointerfaces. 2016. PMID: 27187188 Free article.
Comparison of migration disturbance potency of epigallocatechin gallate (EGCG) synthetic analogs and EGCG PEGylated PLGA nanoparticles in rat neurospheres.
Kühne BA, Puig T, Ruiz-Martínez S, Crous-Masó J, Planas M, Feliu L, Cano A, García ML, Fritsche E, Llobet JM, Gómez-Catalán J, Barenys M. Kühne BA, et al. Among authors: cano a. Food Chem Toxicol. 2019 Jan;123:195-204. doi: 10.1016/j.fct.2018.10.055. Epub 2018 Oct 25. Food Chem Toxicol. 2019. PMID: 30367911
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A, Ettcheto M, Chang JH, Barroso E, Espina M, Kühne BA, Barenys M, Auladell C, Folch J, Souto EB, Camins A, Turowski P, García ML. Cano A, et al. J Control Release. 2019 May 10;301:62-75. doi: 10.1016/j.jconrel.2019.03.010. Epub 2019 Mar 13. J Control Release. 2019. PMID: 30876953 Free PMC article.
A metabolic perspective of late onset Alzheimer's disease.
Ettcheto M, Cano A, Busquets O, Manzine PR, Sánchez-López E, Castro-Torres RD, Beas-Zarate C, Verdaguer E, García ML, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Among authors: cano a. Pharmacol Res. 2019 Jul;145:104255. doi: 10.1016/j.phrs.2019.104255. Epub 2019 May 7. Pharmacol Res. 2019. PMID: 31075308 Free article. Review.
Current Applications of Nanoemulsions in Cancer Therapeutics.
Sánchez-López E, Guerra M, Dias-Ferreira J, Lopez-Machado A, Ettcheto M, Cano A, Espina M, Camins A, Garcia ML, Souto EB. Sánchez-López E, et al. Among authors: cano a. Nanomaterials (Basel). 2019 May 31;9(6):821. doi: 10.3390/nano9060821. Nanomaterials (Basel). 2019. PMID: 31159219 Free PMC article. Review.
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia.
Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A. Folch J, et al. Among authors: cano a. Front Aging Neurosci. 2019 Sep 6;11:236. doi: 10.3389/fnagi.2019.00236. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31551756 Free PMC article.
1,157 results